Schistosomiasis is a tropical disease affecting over 230 million people worldwide. Although effective drug treatment is available, reinfections are common and development of immunity is slow. Most antibodies raised during schistosome infection are directed against glycans, some of which are thought to be protective. Developing schistosomula are considered most vulnerable to immune attack and better understanding of local antibody responses raised against glycans expressed by this life stage might reveal possible glycan vaccine candidates for future vaccine research. We used antibodysecreting cell (ASC) probes to characterize local anti-glycan antibody responses against migrating S. japonicum schistosomula in different tissues of rats. Analysis by shotgun Schistosoma glycan microarray resulted in the identification of anti-glycan antibody response patterns which reflected the migratory pathway of schistosomula. Antibodies raised by skin-lymph node (LN) ASC probes mainly targeted N-glycans with terminal mannose-residues, Galβ1-4GlcNAc (LacNAc) and Galβ1-4(Fucα1-3)GlcNAc (LeX). Also responses towards antigenic and schistosome specific glycosphingolipid (GSL)glycans containing highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches that are believed to be present at the parasite's surface constitutively upon transformation were found. Antibody targets recognized by lung-LN ASC probes were mainly N-glycans presenting GalNAcβ1-4GlcNAc (LDN) and
Introduction
Schistosomiasis is one of the neglected tropical diseases with the highest impact on human health.
Over 230 million people are infected world-wide and over 500 million are at risk of infection [1] [2] [3] . Infection leads to chronic disease characterized by pronounced immunological reactions against eggs deposited into host tissues by the adult schistosome worms that eventually lead to fibrosis and organ failure 2 .
Although effective treatment is available, re-infection occurs rapidly and immunity develops only slowly stressing the need for a prophylactic vaccine as part of a sustainable control strategy [4] [5] [6] .
Schistosomes have a complex lifecycle with different life stages that interact with the human host and that each play a role in immunology, immunopathology and maintenance of infection.
Schistosoma infection occurs after direct contact with water containing the larval form of the parasite (cercariae). Cercariae penetrate the host skin and transform into schistosomula that enter the vasculature and mature while migrating via the lungs to the portal veins. When fully developed, male and female worms pair and, in the case of S. japonicum and S. mansoni, migrate to the mesenteric venous plexus where the female worms start producing eggs. Adult worm pairs can survive for several years producing hundreds of eggs per day unless infection is treated by chemotherapy. The specific location of the different life stages of the schistosome lead to unique interactions with different parts of the host immune system 2, 7 . At the molecular level, the expression of proteins and glycans is developmentally regulated and subject to constant change during schistosome development 8, 9 . This specific antigen expression by different developmental stages could be a strategy to escape the host's immune system, but it may also lead to specific local protective immune responses of the host 10 .
Schistosomula, the migratory larvae, are probably the most important targets of immunity.
Effective elimination of these life stages would prevent the establishment of infection, thereby preventing egg-induced pathology and transmission of the disease. It has been shown in vitro that schistosomula can be targets of effective antibody-mediated immune responses, and that secondary infection in the laboratory rat is a good model of this humoral immunity 11, 12 . IgG1, IgG2 and IgG3 have been associated with killing of schistosomula through an antibody-dependent cellular cytotoxic process mediated by activated as well as non-activated eosinophils 13 . IgG2 has a dual function, as it has cytotoxic activity in the presence of activated eosinophils, while in the presence of non-activated eosinophils it was able to block protective responses. IgG4 has no cytotoxic activity and can block the effects of IgG1, IgG2 and IgG3 13 . Furthermore, other studies have pointed out a role for IgE and IgA in the elimination of schistosomula through similar mechanisms 14, 15 .
Like all other schistosome life stages, schistosomula are abundantly glycosylated. Since schistosome glycans have repeatedly been described as major targets of antibody responses [16] [17] [18] they could play a role in the induction of immunity. Over the past decades glycans expressed during schistosome development have been characterized 9, [19] [20] [21] [22] [23] [24] [25] [26] [27] . Overall, the glycans of schistosomula up to 3 days old were similar to those present in cercariae 9, [20] [21] [22] 24, 26, 27 . N-glycans feature oligomannosyl structures, Galβ1-4GlcNAc (LacNAc) and Galβ1-4(Fucα1-3)GlcNAc (Lewis X or LeX)-antennae and core-xylosylation, while glycosphingolipid (GSL)-glycans are mainly presented with terminal LeX, Fucα1-3Galβ1-4(Fucα1-3)GlcNAc (pseudo-Lewis Y or pseudo-LeY) and multifucosylated GalNAcβ1-4GlcNAc (LacDiNAc or LDN) motifs. O-glycans displaying partly similar motifs were abundantly present Local anti-glycan responses to migratory schistosomula 135 in cercariae, but they gradually disappeared in the developing schistosomula 9 . In contrast, N-glycan expression remained during further development of schistosomula, although the N-glycan profile showed a gradual change towards oligomannosyl glycans and complex-type structures which predominantly expressed LDN-antennae without core-xyloses similar to the adult worm 9, [20] [21] [22] 24, 26, 27 .
The overall GSL-glycan expression remained largely unchanged after transformation and early schistosomula development 9 . Nonetheless, regardless of these overall expression patterns, clear changes in the surface-exposed glycan antigens of early schistosome larvae were observed in studies using anti-glycan monoclonal antibodies and immunofluorescence microscopy. Mono-and multifucosylated LDN-motifs, except LDN-F, present on O-or GSL-glycans were present at the surface before and after transformation, whereas glycans carrying LeX and LDN-F motifs newly appeared at the surface shortly after transformation 28 . Such glycans exposed on the surface of the vulnerable schistosomula may form the targets of antibody-mediated immunity against infection with schistosomes.
To study local antibody responses to glycans of migrating schistosomula we used the antibodysecreting cell (ASC) probe method in rats upon secondary infection with S. japonicum 29, 30 . Rats are semi-permissive hosts for schistosomes as they get infected by cercariae but the parasite does not complete its life cycle. The initial course of infection is normal but rats are capable of a self-cure mechanism resulting in a drop in parasite burden between 3 and 4 weeks after initial infection. Also immunity to reinfection is developed and reinfections are rapidly eliminated, mainly before or during passage through the lung vasculature. These protective responses are antibody-mediated and resemble the type-2 response seen in humans 31, 32 . Therefore, the rat is a good model to study protective immune responses. Using this method it was shown previously that migrating S. japonicum schistosomula in rats induced antibodies in the lung to several high molecular weight protein antigens of larvae and worms as well as antibodies towards synthetic glycan elements including GlcNAc, LeX and LacNAc, and fucosylated N-glycan core-structures 10, 33 . While the use of these non-specific synthetic glycans provided insights into the potential importance of anti-glycan antibodies, the naturally occurring glycans on the surface and in secretions of schistosomula are far more complex than the glycans previously studied, and often carry glycan motifs unique to the schistosome. In the current study we therefore analyzed ASC-probe samples derived from lungs of S. japonicum-infected rats using shotgun glycan microarrays of naturally occurring glycans isolated from several schistosome lifestages. In addition, we included skin ASC probes to study anti-glycan responses that are induced early upon transformation into schistosomula. We show that N-glycans expressing terminal GlcNAc-, LDN-, LeX-and LacNAc-motifs, oligomannosyl glycans and GSL-glycans expressing unique highly fucosylated GalNAcβ1-4(GlcNAc β1)n stretches were the major targets of antibodies raised in the skin of infected rats, whereas antibodies raised in the lung-tissue were predominantly directed against Nglycans expressing non-fucosylated LDN-and terminal GlcNAc-motifs. These observations indicate which glycan structures might be involved in antibody mediated protection against S. japonicum in rats.
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Results
To study the local antibody responses to schistosome glycans, we used ASC probes isolated from rats with a secondary S. japonicum-infection and compared the binding of antibodies generated in skin-and lung-LN using shotgun glycan microarrays. These LN and the timing of their isolation at 5 (I5) and 9 (I9) days after secondary infection reflected the migratory pathway of invading schistosome larvae and corresponded to the expected peak in antibody-production in the skin and lungs, respectively. Glycan LC-fractions showing significant differences in antibody binding between controls (C), I5 and I9 were clustered according to the antibody response patterns raised against the antigenic glycan motifs present in these LC-fractions in a specific LN over time. Glycan-binding patterns were defined for IgG as well as IgM in the skin-and lung-LN ASC probes.
Skin-LN ASC-probes IgG
For the skin-LN ASC probes a total number of 101 LC-fractions, synthetic glycoconjugates and glycoprotein mixtures/isolates showed differential IgG binding that could be grouped in three major glycan clusters ( Fig. 1A ) with different response patterns (Fig. 1C ). Glycan cluster skin-IgG-C1 showed a rise in signal intensity for group I5 compared to the control rats, which remained equally high or slightly increased for group I9. A total of 18 LC-fractions were found within this cluster and these contained mainly N-and GSL-glycans derived from cercariae and eggs ( Fig. 1E ). N-glycans present within these LC-fractions showed numerous different terminal glycan-motifs, including GlcNAc-(egg N-glycan (Table 1 ). Furthermore numerous GSL-glycan fractions present within glycan cluster skin-IgG-C1 were characterized by the presence of highly fucosylated GalNAcβ1-4(GlcNAc β1)n stretches (cercarial GSLglycan fractions 19, 21, 25, egg GSL-glycan fractions 22.1, 23.1, 24.1, 25.2, 26.1) ( Table 1) .
Glycan cluster skin-IgG-C2 also shows a rise in antibody signal intensities for group I5 compared to the control rats which remained equally high or slightly increased for group I9, however signal intensities were lower in comparison with cluster skin-IgG-C1 (Fig. 1C ). Cluster skin-IgG-C2 contains 39 LC-fractions, synthetic glycoconjugates and glycoprotein mixtures/isolates, of which the majority (around 50%) were N-glycans derived from different life stages including cercariae, worms and eggs ( Fig. 1E ). This specific set of N-glycans was characterized by the presence of a wide variety of Local anti-glycan responses to migratory schistosomula 137 (cercarial N-glycan fractions 25, 27.6, 37 , worm N-glycan fractions 6.3, 9, egg N-glycan fractions 13, 15, 17, 20, 27, 29) (Table 1) . Terminal motifs less frequently found within these N-glycans compared to cluster skin-IgG-C1 included LDN-F (cercarial N-glycan fraction 25) and GalNAc1-4(Fuc1-2Fuc1-3)GlcNA1-(LDN-DF) (egg N-glycan fraction 39.2) ( Table 1) . In contrast to skin IgG cluster C1, GSLglycans bearing highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches were absent in cluster skin-IgG-C2. Other LC-fractions found within skin IgG cluster C2 contained GSL-glycans derived from cercariae, displaying either LDN-(cercarial GSL-glycan fraction 32), LeX-(cercarial GSL-glycan fraction 17) or pseudo-LeY-motifs (cercarial GSL-glycan fraction 27) ( Table 1) . One LC-fraction with cercarial Oglycans presenting Fuc1-2Fuc1-3 (DF)-motifs attached to terminal GlcNAc as well as internal LDNmotifs (cercarial O-glycan fraction 16.6) was also found within this cluster ( Table 1 ). Binding of the ASCprobe antibodies to synthetic glycoconjugates related to these motifs was in line with these observations (Table 1 ). Since the antibody-responses within skin IgG clusters C1 and C2 were induced in I5 and sustained in I9, it is likely that the glycan-structures identified within these clusters are associated with the migrating schistosomula or with schistosomula-or cercariae-derived material which is left behind in the skin e.g. secreted glycoproteins, fragments of the glycocalyx or dying schistosomula.
Glycan cluster skin-IgG-C3 showed no change in signal intensity for group I5 compared to the control group but signal intensities increased in group I9 (Fig. 1C ). This cluster contained 12 LCfractions, of which half were cercariae-derived N-glycans ( Fig. 1E ). These N-glycans again contained terminal GlcNAc-(cercarial N-glycan fraction 24), LacNAc-(cercarial N-glycan fraction 24, 29), and LeX-motifs (cercarial N-glycan fraction 29) as well as mannosyl termini (cercarial N-glycan fractions 11, 13) ( Table 1) . Worm derived O-glycans found within this cluster also did contain LeX-and LacNAcmotifs (worm O-glycan fraction 15.5). Also, a specific GSL-glycan sample (egg GSL-glycan fraction HF 9.3) with terminal LDN was observed in this response pattern. Antibody-responses towards these glycan-motifs in this specific context thus seem to be induced after the schistosomula have already left the skin-tissue and migrated towards the lungs, suggesting that these antibodies are triggered by schistosomula-or cercariae-derived material trapped in the skin.
Most notably, these different response patterns show that highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches on GSL-glycans were identified only in cluster skin-IgG-C1, which displayed the largest increases in IgG-signal intensities already in group I5. Furthermore, the IgG response patterns of the skin-LN ASC probes recognize mostly N-and GSL-glycans, whereas O-glycans were hardly recognized. Besides the highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches on GSL-glycans, the N-and GSL-glycans recognized in the different response patterns carry several other terminal motifs, including terminal mannose, terminal GlcNAc, LeX-, LacNAc-and LDN-motifs. These motifs could be found in all identified response patterns.
Lung-LN ASC-probes IgG
For the lung-LN ASC probes a total number of 20 LC-fractions and glycoprotein isolates/mixtures showed differential IgG binding for which we observed three clusters ( Fig. 1B) with different response patterns ( Fig. 1D ). Cluster lung-IgG-C1, which showed a rise in antibody signal intensities for group I5 compared to the control rats and even higher signal intensities for group I9 (Fig. 1D ) only contained two Local anti-glycan responses to migratory schistosomula 141 glycoprotein isolates/mixtures from Schistosoma making it impossible to define which motifs are bound ( Fig. 1F ). Cluster lung-IgG-C2 showed a very similar response pattern as cluster lung IgG-C1, albeit with much lower antibody signal intensities for all groups (Fig. 1D ). This cluster included 5 LC-fractions which were all N-glycans derived from cercariae, adult worms and eggs ( Fig. 1F ). Structures with terminal mannose-residues were detected in most of the LC-fractions of this cluster (worm N-glycan fraction 2.1, 8.5 egg N-glycan fraction 32.5) ( Table 2 ). In addition, structures with LeX (cercarial Nglycan fractions 27, 32.7), LDN-DF (egg N-glycan fraction 32.5) and terminal GlcNAc (cercarial Nglycan fraction 32.7) were observed as well ( Table 2) . It is worth noting that these structures thus already give rise to antibodies in the lung-LN ASC probes very early upon contact with migrating schistosomula, possibly because the time the migrating schistosomula reside in the skin varies and some schistosomula might have already migrated towards the lung-tissue where they can induce immunological reactions 34, 35 .
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Cluster lung-IgG-C3 shows no change in signal intensity for group I5 compared to the control group but signal intensities increased in group I9 (Fig. 1D ), corresponding with the expected peak in antibody production after the schistosomula reached the lungs. This cluster contains 13 LC-fractions, containing exclusively N-and O-glycans derived from adult worms (Fig. 1F) 
Skin-LN ASC-probes IgM
A total of 39 LC-fractions, synthetic glycoconjugates and glycoprotein mixtures/isolates showed differential IgM binding for the skin-LN ASC probes, for which we observed three clusters ( Fig. 2A ) with different response patterns (Fig. 2C) . Cluster skin-IgM-C1 showed an increase in antibody signal intensities in group I5 compared to the control rats, which only slightly decreased in group I9 (Fig. 2C) .
The 4 LC-fractions that were included in this cluster consisted of mostly GSL-glycans from eggs and cercariae (3 LC-fractions), whereas 3 synthetic glycoconjugates were included in this cluster as well ( Fig. 2E) . The GSL-glycans all carried fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches (cercarial GSLglycan fractions 18, 19, egg GSL-glycan fraction 22.1) ( Table 3 ). Furthermore one of the synthetic glycoconjugates found in this cluster was the LDN-F conjugate ( Table 3 ). Another terminal motif frequently observed in LC-fractions within cluster skin-IgM-C1 was the LeX-motif, as part of cercariaederived GSL-glycans and egg-derived O-glycans (cercarial GSL-glycan fraction 19, egg O-glycan fraction 36.2) and as a synthetic glycoconjugate (Table 3 ). Finally, GlcNAc-and F-GlcNAc-motifs were seen as part of egg-derived O-glycans (egg O-glycan fraction 36.2) ( Table 3) .
A total number of 9 LC-fractions and glycoprotein mixtures/isolates was found in cluster skin-IgM-C2, which showed enhanced antibody signal intensities in group I5 compared to the control rats.
However, in group I9 signal intensities decreased to intermediate levels compared to group I5, although
Local anti-glycan responses to migratory schistosomula 143 they were still enhanced compared to the control rats (Fig. 2C ). GSL-glycans derived from eggs and cercariae predominated in this cluster ( Fig. 2E ) and contained structures with DF-LDN-DF-(cercarial GSL-glycan fraction 21, egg GSL-glycan fraction 23.1), LeX-(cercarial GSL-glycan fraction 21) or pseudo LeY-motifs (cercarial GSL-glycan fraction 27). Because the responses observed in skin IgM clusters C1 and C2 showed the highest intensities in group I5 and again decreased in the group I9, these responses nicely reflect the migratory pathway of the schistosomula.
Cluster skin-IgM-C3 did not show changes in signal intensity for group I5 compared to the control rats but signal intensities increased in group I9 (Fig. 2C ). This cluster contained 20 LC-fractions, of which around 38% were cercarial N-glycans. N-and O-glycans of both adult worms and eggs were also found within this cluster (Fig. 2E) . The glycan structures present in cluster skin-IgM-C3 showed numerous different terminal glycan-motifs on different types of glycans (Table 3) (Table 3 ). These glycan structures thus show great similarity (but are not completely identical) with the terminal motifs observed in skin IgG-response clusters C1 and C2 (Table 1) , however the IgM-antibodies recognizing these motifs are induced at a later stage (Fig. 1C,   2C ), when the schistosomula have already migrated out of the skin.
Taken together, the IgM-responses of the skin-LN ASC probes thus target fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches on GSL-glycans at 5 days after secondary infection, at the expected peak in antibody production, possibly together with specific O-and GSL-glycans expressing LeX-and (fucosylated) GlcNAc-motifs. IgM-responses targeting terminal mannose-residues, LeX-and LacNAcmotifs were only observed after the schistosomula already migrated out of the skin.
Lung-LN ASC-probes IgM
Only 4 LC-fractions were differentially recognized by the IgM-responses of the lung-LN ASC probes.
One cluster of 3 LC-fractions was observed (Fig. 2B) . The IgM-antibodies within this cluster lung-IgM-C1 gave only slightly increased signal intensities in group I5 compared to the control group, whereas for group I9 signal intensities were far higher compared to the control group (Fig. 2D ). All LC-fractions found in this cluster were composed of N-glycans derived from adult worms (Fig. 2F) . Most of the glycan structures within these LC-fractions presented terminal LDN-motifs (worm N-glycan fractions 9.2, 10), but LacNAc-motifs (worm N-glycan fraction 9.2) and terminal mannose-residues (worm N-glycan fraction 8.5) were detected as well (Table 4 ). These observations further underline that N-glycans with LDN-and GN-motifs which are expressed by the schistosomula can be targets for antibody-responses when the schistosomula pass through the lungs. 
Discussion
Our data show that anti-glycan antibody responses in skin-and lung-LN ASC probes of S. japonicum infected rats peaked at the time points (5 days and 9 days, respectively) reflecting the migration of the invading larvae. Using an elaborate microarray constructed of naturally occurring glycans isolated from schistosomes, we were able to confirm that in the lung-LN ASC probes antibody responses were mainly directed against N-glycans with terminal GlcNAc-, LeX and LacNAc-motifs and terminal mannoseresidues, like was shown by McWilliam et al. using a glycan-array with synthetic glycan-structures 10 . In addition, we found that LDN-motifs present on N-glycans were also recognized by IgG and IgM produced by lung-LN ASC probes. Furthermore, by defining the different response patterns we revealed that antibodies to N-glycans with LDN-motifs and terminal GlcNAc-and mannose-residues were only significantly detected in the lung LN ASC probes at 9 days post-infection, corresponding with the passage of schistosomula through the lung vasculature around this time-point. Next to the anti-glycan responses in the lung, in this study we also addressed the glycan-structures recognized by responses in the skin-LN ASC probes. For these ASC probes we showed that antibody responses were mostly targeted at N-glycans with terminal mannose residues, LacNAc-, LeX-, GlcNAc-and LDN-motifs and at GSL-glycans with fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches. Antibody levels either peaked at 5 days post-infection and were sustained, or were induced in later infection-stages. Responses towards the fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches present on GSL-glycans were exclusively found among those clusters showing sustained high antibody binding levels up to 9 days post-infection. The sustained binding of antibodies towards all of these different glycans in the skin-LN ASC probes might indicate that at least part of these glycans can still be found in the skin after the schistosomula have already migrated towards the lungs.
Interestingly, antibodies produced by the skin-LN ASC probes only bound to the surface of cercariae and not 24 hr schistosomula 10 . A possible explanation would be the relatively fast migration through the skin and subsequently to the lungs by S. japonicum in combination with a change in surfaceexposed antigens after transformation, thereby preventing the development of antibodies to schistosomula 35 . Cercarial secretions and parts of the cercarial glycocalyx remain in the skin for a longer period of time allowing the immune system to develop local antibody responses to antigenic motifs present in these schistosomal-derived products. Cercarial secretions contain many LacNAc and LeX elements in both the N-and O-glycans 24 . In the glycan microarray analysis we observed a reaction against these types of glycans by skin-LN ASC probes. Particularly the clusters skin-IgG-C1, skin-IgG-Local anti-glycan responses to migratory schistosomula 147 C2 and skin-IgM-C1 showed a prolonged antibody response profile that might be associated with the presence of secretions or material shed into the skin by penetrating cercariae or developing schistosomula, rather than with surface exposed structures. For S. mansoni it was shown that skinstage schistosomula still express glycocalyx-related antigens and leave traces in the skin upon further migration to the lungs [35] [36] [37] [38] and that O-glycans expressed by the glycocalyx are quite abundant and antigenic 20, 39 . However, we observed no significant binding of IgG nor IgM from skin ASC probes to the glycocalyx-associated O-glycans that were on the glycan microarray. This might suggest that the expression level of these O-glycan types is absent or too low to mount an antibody response, or that antibody responses are induced at a later time-point. Alternatively, differences in the O-glycan structures between S. japonicum and S. mansoni might be a reason for the absence of responses towards O-glycans on the microarray since we studied the anti-glycan responses raised towards S. japonicum by making use of a shotgun glycan-microarray containing glycans derived from S. mansoni.
Glycosylation in both species is highly similar based on the limited literature available 22, 40, 41 . The few differences that have been identified are related to glycan structures that are lacking in S. japonicum compared to S. mansoni 40, 41 . Given this high resemblance and in view of the big investment to make a S. japonicum specific array for adding maybe just a few (if there are any) S. japonicum-specific glycans, we decided to use the previously generated S. mansoni glycan microarray to study anti-glycan antibodies induced in S. japonicum infected rats. However, some differences that have to be considered when interpreting our array data have been described as well. First, core-xylosylation is absent from the N-glycans of S. japonicum cercariae, making it likely that this will be the same for schistosomula 22 .
Antibodies to the xylosylated N-glycans as observed in sera of schistosome infected humans and animals would logically be absent in the ASC-probes studied. Furthermore, multi-fucosylated terminal structures expressed in all life stages of S. mansoni 9, 20, 21, 24, 25, 40, 42 and highly antigenic in S. mansoni infection [43] [44] [45] were not detected on protein-nor lipid-linked glycans from eggs of S. japonicum 40, 41 .
Whether such multi-fucosylated terminal motifs, including DF-motifs are present or absent in other lifestages of S. japonicum needs further research. If DF-elements are not expressed by S. japonicum larvae, this would be a possible explanation for the relatively low number of multi-fucosylated O-glycan structures bound by the skin-LN ASC probes. However, some of the GSL-glycans that contained many fucoses were bound by IgM and IgG in skin-LN ASC probes, suggesting that S. japonicum cercariae and/or schistosomula do express this type of GSL-glycan-structures or similar terminal glycan motifs.
Besides differences in expression profiles, the localization of these glycans might also be different across different species indicating that it would be worthwhile investigating the structures and localization of glycans expressed by S. japonicum schistosomula and other life stages.
In the lung-LN ASC probes we observed an intense antibody binding to LDN-and GlcNAcmotifs. LDN-motifs appear to be surface-expressed throughout worm development 19, 45 , but LDNexpression becomes more abundant on N-glycans when the worms mature, while LDN-expression by other types of glycans, especially in later stages of development including lung-stage schistosomula, is hardly present 9 . Together with the previously observed binding of lung-LN ASC-probes to the surface of the developing schistosomula, this indicates that these antibodies were raised against surfaceexposed antigens including N-glycans with LDN-motifs 10 . Responses towards N-glycans displaying Chapter 5
148 LacNAc-and LeX-motifs were also observed for the lung-LN ASC probes. For S. mansoni it has been shown that these motifs are still present in schistosomula up to several days after transformation, especially in the N-glycan pool 9 , and LeX motifs were also shown to be surface exposed on schistosomula 28 . Given the high resemblance of cercarial N-glycans 22 , and expression and antigenicity of LeX 46 between S. mansoni and S. japonicum it is likely that schistosomula of S. japonicum surfaceexpose these motifs also.
Strikingly, in the lung-LN ASC probes we observed no significant IgG nor IgM reaction to the GSL-glycans, whereas these glycans with their highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches were bound by antibodies present in the skin-LN ASC probes. For S. mansoni it has been shown previously that multi-fucosylated GSL-glycans remained expressed in later stages of schistosomula development 9 , are surface-exposed 28 , and have been shown to be major targets of antibody response in sera of infected individuals [43] [44] [45] 47 . The reason why we did not observe significant binding for lung-LN ASC probes might be because of differences in the expression of these glycans between S. mansoni and S. japonicum. Since S. japonicum does not express multi-fucosylated motifs in the egg stages 40, 41 , it is possible that multi-fucosylated motifs are shed by S. japonicum cercariae or schistosomula in the skin and are not further expressed in subsequent stages. There might be a gradual change during maturation, so that multi-fucosylated LDN-motifs are already replaced by other (less antigenic) structures when the schistosomula reach the lungs. For S. mansoni it was determined that proteinlinked multi-fucosylated glycans disappear from the schistosomula glycome after 3 days, whereas GSLlinked DF-elements remain in the overall spectrum, as well as exposed at the surface 9,28 . If these expression patterns would be similar for S. japonicum an alternative explanation for the absence of reactivity in the lung could be due to the differential expression on protein and lipid carriers. Little is known about the mechanisms by which antibodies to protein-linked glycans are generated, and knowledge about how anti-GSL glycan antibodies are induced is even more negligible.
Through the combined use of ASC probes and shotgun glycan microarrays we identified the anti-glycan responses raised against migrating schistosomula in rats. These local recognition profiles are broad given the variety of glycans expressed by Schistosoma 9 . Our data indicate that N-glycans with terminal mannose residues, LacNAc-motifs and LeX-motifs, abundantly present in secretions of cercariae and schistosomula together with GSL-glycans containing fucosylated LDN-and GlcNAcmotifs, were major targets of antibody-responses raised in the skin-LN ASC probes. Antibodies raised in the lung-LN ASC-probes were mainly directed towards N-glycans presenting LDN and GlcNAcmotifs, most likely present at the surface of the migrating schistosomula. Since antibody-dependent mechanisms primarily mediate the resistance to infection in rats 12 , each of the glycans recognized by these local immune responses possibly plays a role in elimination of the parasite. Given the breath of the recognition profile it is yet impossible to define individual glycan structures that might be involved in protection. Antibodies raised against glycans are specific for certain glycan elements, but might not be functional in inducing protection. In addition, some of the glycan structures and glycan elements recognized, might also be expressed by the host and are therefore not considered good vaccine candidates. Since the expression of glycans and antibodies raised against these glycans is so broad, it might also be worthwhile testing whether this polyvalent expression plays a role in generating protective Local anti-glycan responses to migratory schistosomula 149 immune responses. Future studies are therefore needed to further investigate the specific role of antigenic glycans and glycan elements in the parasite-host interaction and explore the possible role of antibodies against parasite glycan motifs in antibody-mediated protection against S. japonicum infection.
Materials and Methods

ASC probes
ASC probes were produced as described previously 10 . In short, a Chinese strain of Oncomelania hupensis snails (Anhui province, PR of China) was used to obtain S. japonicum cercariae, which were subsequently used for the infection of female Wistar-rats. Rats were infected percutaneously with 125 (primary infection) and 350 cercariae (secondary infection, 6 weeks after primary infection). Axillary and inguinal lymph nodes (LN) (skin-LN) and mediastinal LN (lung-LN) were isolated from an uninfected control group, and from two groups of rats at 5 and 9 days after secondary infection, respectively. Timing of the isolation of LN corresponded to the expected peak in antibody-production in the skin-(5 days post-infection) and lung-LN (9 days post-infection) 10 . The LN were dissected, cell suspensions were made and cultured at 37C and 5% CO2 for 5 days. Supernatants containing antibodies secreted by in vivo induced ASCs (ASC-probes), were then collected and used for incubation on glycan microarrays.
Glycan microarray development
In previous studies the development of glycan arrays has been described extensively 39, 48 . Briefly, Nglycans, O-glycans and GSL-glycans were obtained from cercariae, adult worms and eggs from a Puerto Rican-strain of S. mansoni. 2-aminobenzoic acid (2-AA) derivatized glycans were fractionated in two dimensions by hydrophilic interaction liquid chromatography (HILIC)-and reversed phase-liquid chromatography (RP-LC) and the collected glycan-containing fractions were subsequently printed in triplicate to epoxysilane-coated glass slides together with synthetic glycoconjugates. Three individual arrays were printed to each glass slide, each array containing a total number of 888 LC-fractions (127 from cercarial N-glycans, 115 from adult worm N-glycans, 110 from egg N-glycans, 37 from cercarial GSL-glycans, 66 from egg GSL-glycans, 137 from cercarial O-glycans, 79 from adult worm O-glycans, centrifugation, slides were stored in the dark before scanning. Scanning was performed using a G2565BA scanner (Agilent Technologies, Santa Clara, CA) at 10 µM resolution with 2 lasers (532 nm and 633 nm). Scanned images were analyzed with Genepix Pro 7.0 software. Spots were aligned and resized using round features and no CPI-threshold. Background subtracted median fluorescence intensities of each of the spots were then averaged for each glycan sample. Datasets were log2 transformed to remove the basic trends of variance.
Response patterns and statistics
LC-fractions showing a significant difference in signal intensities for the different ASC probes were identified using analysis of variance (ANOVA) (p<0.05) and were grouped based on response patterns using hierarchical clustering analysis (HCA, complete linkage clustering using Euclidean distance).
Branches with about the same horizontal distribution and strongest/largest distance between each cluster were used to classify the most discriminative clusters.
Mass spectrometry and structural assignments
LC-fractions were analyzed by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) using Ultraflex II and Ultraflextreme mass spectrometers (Bruker Daltonics, Bremen, Germany) in negative-ion reflectron mode with 2,5-dihydroxybenzoic acid (DHB;
Bruker Daltonics) as matrix. Detected masses were translated into putative glycan structures using Glycopeakfinder (http://glyco-peakfinder.org), literature 9, [19] [20] [21] [22] [23] [24] [25] [26] [27] [40] [41] [42] [49] [50] [51] and own unpublished MS/MS data. The three most abundant signals in each mass spectrum were translated into glycan structures, unless individual signals made up less than 10% of the total intensity of all glycan masses in the spectrum of a glycan sample.
